A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Moxifloxacin-d4 | Moxifloxacin-d 4 is the deuterium labeled Moxifloxacin. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2]. Uses: Scientific research. Group: Isotope-labeled compounds. Alternative Names: BAY 12-8039-d4 free base. CAS No. 2596386-23-9. Pack Sizes: 1 mg. Product ID: HY-66011AS. |  |
| Moxifloxacin-[d4] Hydrochloride | Moxifloxacin-[d4] Hydrochloride is a labelled salt of Moxifloxacin. Moxifloxacin exerts its effects by trapping a DNA drug enzyme complex and specfically inhibiting ATP-dependent enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. Synonyms: 1-Cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl-5,5,7,7-d4)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride; Moxifloxacin D4 Hydrochloride; 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid-d4 hydrochloride; Moxifloxacin-d4 HCl. Grade: >95%. Molecular formula: C21H20D4FN3O4.HCl. Mole weight: 441.92. |  |
| Moxifloxacin EP Impurity B | Moxifloxacin EP Impurity B. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-cyclopropyl-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-6,8-dimethoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. CAS No. 1029364-73-5. Molecular formula: C22H27N3O5. Mole weight: 413.47. Catalog: APB1029364735. |  |
| Moxifloxacin EP Impurity C | Moxifloxacin EP Impurity C. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-Cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride. CAS No. 1029364-75-7. Molecular formula: C22H26FN3O4. Mole weight: 415.46. Catalog: APB1029364757. | |
| Moxifloxacin EP Impurity D | Moxifloxacin EP Impurity D. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-cyclopropyl-8-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-6-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. CAS No. 1029364-77-9. Molecular formula: C21H24FN3O4. Mole weight: 401.43. Catalog: APB1029364779. | |
| Moxifloxacin HCI | Moxifloxacin hydrochloride is thus developed by Germany's bayer pharmaceutical a fluoroquinolone antibiotic medicine, action mechanism and the in vitro antibacterial spectrum similar to other fluoroquinolone drugs, but the antibacterial activity of gram positive bacteria and anaerobic bacteria and cut (trovafloChemicalbookxacin) similar characters, better than some of the old varieties. CAS No. 186826-86-8. Product ID: PAP-0064. Molecular formula: C21H25ClFN3O4. Category: Antibiotic. Product Keywords: Antibacterial, Anti-inflammatory and Antiviral Series; Moxifloxacin HCI; PAP-0064; Antibiotic; C21H25ClFN3O4; 186826-86-8. Appearance: Powder. Standard: USP/EP. Grade: CEP/ISO. Color: white to beige. Physical State: powder. Solubility: H2O: soluble5mg/mL, clear (warmed). Storage: 2-8°C. Applications: It is an antibiotic used to treat bacterial infections of the lungs, paranasal sinuses, skin and abdominal cavity in adults. Boiling Point: 636°C. Melting Point: Slightly yellow to yellow crystalline powder, mp 324-325°. |  |
| Moxifloxacin hydrochloride | 1g Pack Size. Group: Antibiotics, Bioactive Small Molecules. Formula: C21H24FN3O4 ¢HCl. CAS No. 186826-86-8. Prepack ID 85126157-1g. Molecular Weight 437.89. See USA prepack pricing. |  |
| Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride is the hydrochloride salt preparation of Moxifloxacin, an 8-methoxy-fluoroquinone compound with broad-spectrum bactericidal activity against gram-positive and gram-negative strains. 8-methoxy-fluoroquinones are described to inhibit the activities of DNA gyrase and topoisomerase IV. The 8-methoxy group of Moxifloxacin is suggested to confer a lowered propensity for resistance development as compared to other C-8 substituted quinolones, and Moxifloxacin demonstrates potent activity against wild-type and first-step gyrase- and topoisomerase IV-resistant mutants. Moxifloxacin shows activity against methicillin-susceptible staphylococci, penicillin-susceptible and penicillin-resistant pneumococci, penicillin-susceptible and penicillin-resistant viridans group streptococci, group A streptococci, M. catarrhalis, and H. influenzae in vitro. Group: Biochemicals. Alternative Names: (1'S,6',S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride; 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride. Grades: Highly Purified. CAS No. 186826-86-8. Pack Sizes: 5g, 10g, 25g, 50g, 100g. US Biological Life Sciences. |  Worldwide |
| Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BAY 12-8039. CAS No. 186826-86-8. Pack Sizes: 50 mg; 100 mg; 500 mg. Product ID: HY-66011. | |
| Moxifloxacin Hydrochloride | Moxifloxacin exerts its effects by trapping a DNA drug enzyme complex and specifically inhibiting ATP-dependent enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. It is a fluoroquinolone antibiotic with broad-spectrum bactericidal activity against gram-positive and gram-negative strains. Synonyms: BAY12-8039 HCl; BAY12 8039 HCl; BAY128039 HCl; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride (1:1); Actira; Avalox; Lapinix; Moxifloxacine Hydrochloride; Octegra. Grade: >98%. CAS No. 186826-86-8. Molecular formula: C21H24FN3O4.HCl. Mole weight: 437.89. | |
| Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-Dihydroquinoline-3-carboxylic acid hydrochloride. Product Category: Inhibitors. CAS No. 186826-86-8. Molecular formula: C21H25ClFN3O4. Mole weight: 437.9. Purity: 0.98. Product ID: ACM186826868. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Moxifloxacin Hydrochloride-13CD3 | A fluorinated quinolone antibacterial. Group: Biochemicals. Alternative Names: 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid-13CD3 Hydrochloride; BAY-12-8039-13CD3; Actira-13CD3; Avalox-13CD3; Proflox-13CD3. Grades: Highly Purified. CAS No. 1246816-75-0. Pack Sizes: 2.5mg. US Biological Life Sciences. | Worldwide |
| Moxifloxacin Hydrochloride HCL | Moxifloxacin Hydrochloride is the hydrochloride salt of a fluoroquinolone antibacterial antibiotic. Moxifloxacin binds to and inhibits the bacterial enzymes DNA gyrase (topoisomerase II) and topoisomerase IV, resulting in inhibition of DNA replication and repair and cell death in sensitive bacterial species. Alternative Names: Moxifloxacin HCl. Avelox. Vigamox. CAS No. 186826-86-8. Product ID: API186826868. Molecular formula: C21H25ClFN3O4. Mole weight: 437.9. EINECS: 641-756-7. SMILES: COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl. Appearance: Yellow Powder. Standard: EP/USP. Category: Antibacterial APIs. |  |
| Moxifloxacin hydrochloride monohydrate | Moxifloxacin hydrochloride monohydrate. Group: Biochemicals. Alternative Names: 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride; BAY-12-8039; Actira. Grades: Highly Purified. CAS No. 192927-63-2. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C21H27ClFN3O5. US Biological Life Sciences. | Worldwide |
| Moxifloxacin Hydrochloride Monohydrate | Moxifloxacin Hydrochloride Monohydrate. Uses: For analytical and research use. Group: Chiral molecules. Alternative Names: 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride, hydrate (1:1:1), Moxifloxacin hydrochloride monohydrate, 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, monohydrochloride, monohydrate, (4aS-cis)-, 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, monohydrochloride, monohydrate (9CI). CAS No. 192927-63-2. Pack Sizes: 10MG. IUPAC Name: 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrate;hydrochloride. Molecular formula: C21H24FN3O4.ClH.H2O. Mole weight: 455.91. Catalog: APS192927632. SMILES: O.Cl.COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(=O)O. Format: Neat. Shipping: Room Temperature. | |
| Moxifloxacin Hydrochloride Monohydrate (BAY-12-8039, Actira, Avalox, Proflox,1-Cyclopropyl-6-fluoro-1,4-dihydro- 8-methoxy-7- [(4αS,7αS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid Hydrochloride) | A fluorinated quinolone antibacterial. Group: Biochemicals. Alternative Names: BAY-12-8039, Actira, Avalox, Proflox,1-Cyclopropyl-6-fluoro-1,4-dihydro- 8-methoxy-7- [(4αS,7αS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid Hydrochloride. Grades: Highly Purified. CAS No. 192927-63-2. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Moxifloxacin impurity 103 | Moxifloxacin impurity 103. Uses: For analytical and research use. Group: Impurity standards. CAS No. 100-75-4. Molecular formula: C5H10N2O. Mole weight: 114.15. Catalog: APB100754. | |
| Moxifloxacin impurity 106 | Moxifloxacin impurity 106. Uses: For analytical and research use. Group: Impurity standards. CAS No. 112811-66-2. Molecular formula: C8H4ClF3O2. Mole weight: 224.56. Catalog: APB112811662. | |
| Moxifloxacin impurity 108 | Moxifloxacin impurity 108. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1403836-23-6. Molecular formula: C23H28FN3O4. Mole weight: 429.49. Catalog: APB1403836236. | |
| Moxifloxacin impurity 109 | Moxifloxacin impurity 109. Uses: For analytical and research use. Group: Impurity standards. CAS No. 112811-70-8. Molecular formula: C16H16F3NO4. Mole weight: 343.3. Catalog: APB112811708. | |
| Moxifloxacin Impurity 24 | Moxifloxacin Impurity 24. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxyquinolin-4(1H)-one. CAS No. 1322062-57-6. Molecular formula: C20H24FN3O2. Mole weight: 357.42. Catalog: APB1322062576. | |
| Moxifloxacin Impurity 30 | Moxifloxacin Impurity 30. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 7-(3-(2-carboxyethyl)-4-(hydroxyamino)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. CAS No. 1395056-42-4. Molecular formula: C21H24FN3O7. Mole weight: 449.43. Catalog: APB1395056424. | |
| Moxifloxacin Impurity 35 | Moxifloxacin Impurity 35. Uses: For analytical and research use. Group: Impurity standards. CAS No. 151213-39-7. Molecular formula: C14H20N2. Mole weight: 216.33. Catalog: APB151213397. | |
| Moxifloxacin Impurity 39 | Moxifloxacin Impurity 39. Uses: For analytical and research use. Group: Impurity standards. CAS No. 151213-45-5. Molecular formula: C8H16N2. Mole weight: 140.23. Catalog: APB151213455. | |
| Moxifloxacin Impurity 42 | Moxifloxacin Impurity 42. Uses: For analytical and research use. Group: Impurity standards. CAS No. 11281-65-5. Molecular formula: C8H5F3O3. Mole weight: 206.12. Catalog: APB11281655. | |
| Moxifloxacin Impurity 44 | Moxifloxacin Impurity 44. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1048972-52-6. Molecular formula: C14H12FNO5. Mole weight: 293.25. Catalog: APB1048972526. | |
| Moxifloxacin Impurity 51 | Moxifloxacin Impurity 51. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1395056-41-3. Molecular formula: C21H22FN3O5. Mole weight: 415.42. Catalog: APB1395056413. | |
| Moxifloxacin Impurity 75 | Moxifloxacin Impurity 75. Uses: For analytical and research use. Group: Impurity standards. CAS No. 141290-02-0. Molecular formula: C15H13F2NO4. Mole weight: 309.26. Catalog: APB141290020. | |
| Moxifloxacin Impurity 80 | Moxifloxacin Impurity 80. Uses: For analytical and research use. Group: Impurity standards. CAS No. 133492-64-5. Molecular formula: C8H3F4NO3. Mole weight: 237.11. Catalog: APB133492645. | |
| Moxifloxacin Impurity 87 | Moxifloxacin Impurity 87. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1395471-03-0. Molecular formula: C21H24FN3O5. Mole weight: 417.44. Catalog: APB1395471030. | |
| Moxifloxacin Impurity 89 | Moxifloxacin Impurity 89. Uses: For analytical and research use. Group: Impurity standards. CAS No. 151213-40-0. Molecular formula: C7H14N2. Mole weight: 126.2. Catalog: APB151213400. | |
| Moxifloxacin Impurity 91 | Moxifloxacin Impurity 91. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-3-hydroxy-8-methoxyquinolin-4(1H)-one. CAS No. 1395471-18-7. Molecular formula: C20H24FN3O3. Mole weight: 373.42. Catalog: APB1395471187. | |
| Moxifloxacin Impurity A HCl | Moxifloxacin Impurity A HCl. Uses: For analytical and research use. Group: Impurity standards. CAS No. 151282-23-4. Molecular formula: C20H21F2N3O3·HCl. Mole weight: 425.86. Catalog: APB151282234. | |
| Moxifloxacin Impurity A (Moxifloxacin hydrochloride EP impurity A) | Moxifloxacin Impurity A (Moxifloxacin hydrochloride EP impurity A). Uses: For analytical and research use. Group: Impurity standards. CAS No. 151213-15-9. Molecular formula: C20H21F2N3O3. Mole weight: 389.4. Catalog: APB151213159. | |
| Moxifloxacin Impurity G | Moxifloxacin Impurity G. Uses: For analytical and research use. Group: Impurity standards. CAS No. 112811-71-9. Molecular formula: C16H15F2NO4. Mole weight: 323.29. Catalog: APB112811719. | |
| Moxifloxacin Impurity I | Moxifloxacin Impurity I. Uses: For analytical and research use. Group: Impurity standards. CAS No. 139693-52-0. Molecular formula: C19H17F2NO8. Mole weight: 425.34. Catalog: APB139693520. | |
| Moxifloxacin Impurity J | Moxifloxacin Impurity J. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid. CAS No. 112811-72-0. Molecular formula: C14H11F2NO4. Mole weight: 295.24. Catalog: APB112811720. | |
| Moxifloxacin Impurity Q | Moxifloxacin Impurity Q. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1329836-33-0. Molecular formula: C16H15F2NO4. Mole weight: 323.3. Catalog: APB1329836330. | |
| Moxifloxacin Impurity V | Moxifloxacin Impurity V. Uses: For analytical and research use. Group: Impurity standards. CAS No. 112811-67-3. Molecular formula: C15H15F3O6. Mole weight: 348.27. Catalog: APB112811673. | |
| Moxifloxacin Impurity Z | Moxifloxacin Impurity Z. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-cyclopropyl-6,7-difluoro-8-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. CAS No. 154093-72-8. Molecular formula: C13H9F2NO4. Mole weight: 281.21. Catalog: APB154093728. | |
| Moxifloxacin N-Sulfate Disodium Salt | A sulfometabolite of Moxifloxacin. Group: Biochemicals. Alternative Names: 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-1-sulfo-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Disodium Salt. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Moxifloxacin Related Compound A | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moxifloxacin Related Compound B | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moxifloxacin Related Compound C | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moxifloxacin Related Compound D | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moxifloxacin Related Compound E | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moxifloxacin Related Compound F | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Moxifloxacin RR-Isomer HCl | Moxifloxacin RR-Isomer HCl. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1394029-14-1. Molecular formula: C21H25ClFN3O4. Mole weight: 437.9. Catalog: APB1394029141. | |
| Moxifloxacin (Standard) | Moxifloxacin (Standard) is the analytical standard of Moxifloxacin. This product is intended for research and analytical applications. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia [1] [2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 151096-09-2. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-66011AR. | |
| Moxilubant | Moxilubant (CGS-25019C;LTB-019) is an orally active BLT1 antagonist which inhibits LTB4 signaling with a potency of 2 - 4 nM. Moxilubant can be used for cancer research [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: CGS 25019C free base. CAS No. 146978-48-5. Pack Sizes: 5 mg; 10 mg. Product ID: HY-106929. | |
| Moxisylyte hydrochloride | Moxisylyte (hydrochloride) is (alpha 1-blocker) antagonist, it can vasodilates cerebral vessels without reducing blood pressure. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Thymoxamine hydrochloride. CAS No. 964-52-3. Pack Sizes: 10 mM * 1 mL; 25 mg; 50 mg; 100 mg. Product ID: HY-B1435. | |
| Moxisylyte Hydrochloride | >99% (TLC), powder. Group: Fluorescence/luminescence spectroscopyapi standardspharmaceutical toxicology. Alternative Names: Moxilite, Thymoxamine, [2-(4-Acetoxy-2-isopropyl-5-methylphenoxy)ethyl]dimethylamine, Carvacrol, 5-[2-(dimethylamino)ethoxy]-, acetate (ester) (8CI), 6-Acetoxythymol 2-(dimethylamino)ethyl ether, Moxisylite, Moxisylyt, 4-(2-Dimethylaminoethoxy)-2-methyl-5-isopropylphenyl acetate, Timoxamina, 4-(2-Dimethylaminoethoxy)-5-isopropyl-2-methylphenyl acetate, Arlytene, Sympal, Carvacrol, 5-[2-(dimethylamino)ethoxy]-, acetate (6CI,7CI), [(6-Acetoxythymoxy)ethyl]dimethylamine, Moxisylyte, 5-[2-(Dimethylamino)ethoxy]carvacrol acetate, Phenol, 4-[2-(dimethylamino)ethoxy]-2-methyl-5-(1-methylethyl)-, acetate (ester) (9CI),Thymoxamine Hydrochloride, Phenol, 4-[2-(dimethylamino)ethoxy]-2-methyl-5-(1-methylethyl)-, 1-acetate. | |
| Moxonidine | Moxonidine is an antihypertensive agent. Group: Biochemicals. Alternative Names: 4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine; 2-(6-Chloro-4-methoxy-2-methylpyrimidin-5-ylamino)-2-imidazoline; Lomox; Moxon; Norcynt; Normoxocin; Nucynt; Physiotens. Grades: Highly Purified. CAS No. 75438-57-2. Pack Sizes: 25mg. US Biological Life Sciences. | Worldwide |
| Moxonidine | Moxonidine (BDF5895) is an imidazoline type 1 receptor (I1-R) selective agonist and antihypertensive agent. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BDF5895. CAS No. 75438-57-2. Pack Sizes: 10 mM * 1 mL; 100 mg. Product ID: HY-B0374. | |
| Moxonidine-[d4] | Moxonidine-[d4] is the labelled analogue of Moxonidine. Moxonidine is a selective agonist at the imidazoline receptor subtype (I1). It binds with much greater affinity to the imidazoline I1-receptor than to the α2-receptor while clonidine binds to both receptors with equal affinity. Synonyms: Moxonidine D4; 4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl-d4)-6-methoxy-2-methyl-5-pyrimidinamine; 2-(6-Chloro-4-methoxy-2-methylpyrimidin-5-ylamino)-2-imidazoline-d4. Grade: 95% by HPLC; 95% atom D. CAS No. 1794811-52-1. Molecular formula: C9H8D4ClN5O. Mole weight: 245.7. | |
| Moxonidine hydrochloride | ?98%. Group: Fluorescence/luminescence spectroscopy. | |
| Moxonidine hydrochloride | Moxonidine Hydrochloride is a selective agonist at the imidazoline receptor subtype 1, used as antihypertensive agent. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BDF5895 hydrochloride. CAS No. 75536-04-8. Pack Sizes: 10 mM * 1 mL; 5 mg. Product ID: HY-B0374A. | |
| Moxonidine hydrochloride | Moxonidine hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 75536-04-8. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| MP265 | MP265 (4-Chlorobenzyl carbamimidothioate hydrochloride) is a structural analogue of A22 but is less toxic. MP265 is a MreB inhibitor[1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: 4-Chlorobenzyl carbamimidothioate hydrochloride. CAS No. 544-47-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-131583. | |
| MP7 | MP7 (PDK1 inhibitor) is a phosphoinositide-dependent kinase-1 ( PDK1 ) inhibitor. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PDK1 inhibitor. CAS No. 1001409-50-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-14440. | |
| MPAC-Br | MPAC-Br. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 3-[4-(Bromomethyl)phenyl]7-(diethylamino)-coumarin. Product Category: Other Fluorophores. Appearance: Yellow to brown crystals. CAS No. 177093-58-2. Molecular formula: C20H20BrNO2. Mole weight: 386.28. Purity: 98%+. IUPACName: 3-[4-(bromomethyl)phenyl]-7-(diethylamino)chromen-2-one. Canonical SMILES: CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C3=CC=C(C=C3)CBr. Product ID: ACM177093582-1. Alfa Chemistry ISO 9001:2015 Certified. Categories: 3-[4-(Bromomethyl)phenyl]-7-(diethylamino)coumarin, Mac Brunson. | |
| MPC-3100 | MPC-3100 is a recently discovered fully synthetic purine-based Hsp90 Inhibitor exhibiting anticancer properties. Group: Biochemicals. Alternative Names: (2S)-1-[4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl]ethyl]-1-piperidinyl]-2-hydroxy-1-propanone. Grades: Highly Purified. CAS No. 958025-66-6. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| MPC 6827 hydrochloride | MPC 6827 hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 917369-31-4. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| MPDC | MPDC. Group: Biochemicals. Grades: Purified. CAS No. 159262-32-5. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| mPEG10K-Propionaldehyde | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Propionaldehyde, mPEG-ALD, Methoxy-PEG-Propionaldehyde. Molecular formula: average Mn 10000. |  |
| mPEG10K-Propionaldehyde | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG10K-Succinimidyl Carboxymethyl Ester | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| mPEG10K-Succinimidyl Carboxymethyl Ester | Methoxy PEG NHS Ester (SCM PEG). Amine reactive PEG towards the amino groups of lysine(s) on proteins or other biologics; reaction occurs at room temperature in <1hr at pH 7-8. Stable linker between PEG and NHS ester. Uses: S may include: bioconjugation, drug delivery, peg hydrogel, crosslinker, and surface functionalization. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 10000. | |
| m-PEG12-acid | m-PEG12-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2135793-73-4. Pack Sizes: 50 mg; 100 mg; 250 mg. Product ID: HY-135820. | |
| mPEG12-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
Our database is helping our users find suppliers everyday.
